These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 21308719
1. SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells. Horndasch M, Culig Z. Prostate; 2011 Sep; 71(12):1357-66. PubMed ID: 21308719 [Abstract] [Full Text] [Related]
2. Resveratrol sensitizes androgen independent prostate cancer cells to death-receptor mediated apoptosis through multiple mechanisms. Gill C, Walsh SE, Morrissey C, Fitzpatrick JM, Watson RW. Prostate; 2007 Nov 01; 67(15):1641-53. PubMed ID: 17823925 [Abstract] [Full Text] [Related]
3. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Shankar S, Siddiqui I, Srivastava RK. Mol Cell Biochem; 2007 Oct 01; 304(1-2):273-85. PubMed ID: 17636462 [Abstract] [Full Text] [Related]
4. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand. Yasuda T, Yoshida T, Goda AE, Horinaka M, Yano K, Shiraishi T, Wakada M, Mizutani Y, Miki T, Sakai T. Mol Cancer Res; 2008 Dec 01; 6(12):1852-60. PubMed ID: 19074830 [Abstract] [Full Text] [Related]
5. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN. Cancer Res; 2001 Jan 15; 61(2):759-63. PubMed ID: 11212279 [Abstract] [Full Text] [Related]
6. Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells. Festuccia C, Gravina GL, D'Alessandro AM, Millimaggi D, Di Rocco C, Dolo V, Ricevuto E, Vicentini C, Bologna M. Int J Oncol; 2008 Aug 15; 33(2):381-8. PubMed ID: 18636160 [Abstract] [Full Text] [Related]
7. Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5. Lee YJ, Seol JW, Jeong JK, Moon MH, Park SY. Mol Med Rep; 2011 Aug 15; 4(6):1255-9. PubMed ID: 21850375 [Abstract] [Full Text] [Related]
8. Clusterin mediates TRAIL resistance in prostate tumor cells. Sallman DA, Chen X, Zhong B, Gilvary DL, Zhou J, Wei S, Djeu JY. Mol Cancer Ther; 2007 Nov 15; 6(11):2938-47. PubMed ID: 18025278 [Abstract] [Full Text] [Related]
9. Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells. Perego P, Ciusani E, Gatti L, Carenini N, Corna E, Zunino F. Biochem Pharmacol; 2006 Mar 14; 71(6):791-8. PubMed ID: 16438941 [Abstract] [Full Text] [Related]
10. Ursolic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Shin SW, Park JW. Biochim Biophys Acta; 2013 Mar 14; 1833(3):723-30. PubMed ID: 23247106 [Abstract] [Full Text] [Related]
11. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism. Ortiz-Ferrón G, Yerbes R, Eramo A, López-Pérez AI, De Maria R, López-Rivas A. Cell Res; 2008 Jun 14; 18(6):664-76. PubMed ID: 18458681 [Abstract] [Full Text] [Related]
12. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Zhang X, Li W, Olumi AF. Clin Cancer Res; 2007 Dec 01; 13(23):7181-90. PubMed ID: 18056199 [Abstract] [Full Text] [Related]
13. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells. Yoo J, Park SS, Lee YJ. J Cell Biochem; 2008 Aug 01; 104(5):1636-46. PubMed ID: 18404675 [Abstract] [Full Text] [Related]
14. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis. Peuhu E, Rivero-Müller A, Stykki H, Torvaldson E, Holmbom T, Eklund P, Unkila M, Sjöholm R, Eriksson JE. Oncogene; 2010 Feb 11; 29(6):898-908. PubMed ID: 19935713 [Abstract] [Full Text] [Related]
15. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Szliszka E, Helewski KJ, Mizgala E, Krol W. Int J Oncol; 2011 Oct 11; 39(4):771-9. PubMed ID: 21743964 [Abstract] [Full Text] [Related]
16. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA, Gautam SC. J Pharmacol Exp Ther; 2007 May 11; 321(2):616-25. PubMed ID: 17289836 [Abstract] [Full Text] [Related]
17. Tunicamycin sensitizes human prostate cells to TRAIL-induced apoptosis by upregulation of TRAIL receptors and downregulation of cIAP2. Jung YH, Lim EJ, Heo J, Kwon TK, Kim YH. Int J Oncol; 2012 Jun 11; 40(6):1941-8. PubMed ID: 22426894 [Abstract] [Full Text] [Related]
18. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Tong X, Li H. Cancer Lett; 2004 Jul 08; 210(1):63-71. PubMed ID: 15172122 [Abstract] [Full Text] [Related]
19. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639 [Abstract] [Full Text] [Related]
20. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Yoo J, Lee YJ. Mol Pharmacol; 2007 Dec 15; 72(6):1586-92. PubMed ID: 17848598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]